Inhibrx Biosciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · La Jolla, CA
INBX chart
What traders are saying about $INBX
Latest postsInhibrx Biosciences, Inc. news
- Avoiding Lag: Real-Time Signals in (INBX) Movement
Stock Traders Daily ·
- Inhibrx Biosciences, Inc. (INBX) stock price, news, quote and history
Yahoo Finance UK ·
- Inhibrx Biosciences, Inc. Estimates – NASDAQ:INBX
TradingView ·
- Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Inhibrx Stock Price Forecast. Should You Buy INBX?
StockInvest.us ·
- Inhibrx Biosciences (INBX) Stock Looks Hard To Pin Down At This Price
Yahoo Finance ·
- Insiders Load Up on These 2 ‘Strong Buy’ Stocks — Should You Follow Their Footsteps?
Yahoo Finance ·
- Are Inhibrx Biosciences' (INBX) Global Data Reveals Reframing Its Late-Stage Pipeline Credibility?
Yahoo Finance ·
- Inhibrx Announces Participation in Upcoming Scientific Conferences
Yahoo Finance ·
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
marketbeat.com ·
- Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating
Yahoo Finance ·
- Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall?
Yahoo Finance ·
Inhibrx Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $1.3M | $200,000 | $1.8M |
| Net income | -$140.1M | $1.69B | -$241.4M |
| Diluted EPS | $-9.04 | $112.62 | $-20.48 |
| Total assets (year end) | $146.5M | $180.8M | $307.9M |
| Cash and equivalents (year end) | $124.2M | $152.6M | $277.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Inhibrx Biosciences, Inc.
- Ticker
- INBX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- La Jolla, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2007919
Frequently asked questions
What exchange is Inhibrx Biosciences, Inc. listed on?
Inhibrx Biosciences, Inc. trades on the Nasdaq under the ticker symbol INBX.
What industry is Inhibrx Biosciences, Inc. in?
Inhibrx Biosciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Inhibrx Biosciences, Inc. headquartered?
Inhibrx Biosciences, Inc.'s business address on file with the SEC is in La Jolla, CA.
When does Inhibrx Biosciences, Inc.'s fiscal year end?
Inhibrx Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Inhibrx Biosciences, Inc. report?
Inhibrx Biosciences, Inc. reported $1.3M in revenue for calendar year 2025, according to its SEC filings.